Tranexamic Acid Chemical Structure (Figure 1)
Tranexamic Acid Tablet
Product Images NDC 72319-028
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 72319-028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by I3 Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Menstrual Bleeding Loss Levels Over Duration Of Therapy In Women With Heavy Menstrual Bleeding (studies 1 And 2) (Figure 2)
Tranexamic Acid Tablets 650 mg Container Label (Figure 3)
Each tablet contains 650 mg tranexamic acid, USP. The usual adult dosage is two 650-mg tablets taken three times daily (3.9 g/day) for the drug Tranexamic Acid. It is important not to exceed 6 tablets in a 24-hour period. The tablets should be stored at 25°C (77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). It is recommended to refer to the package insert for complete prescribing information. This medication should be kept in a tight, light-resistant container with a child-resistant closure and out of the reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
